maraviroc (cont.)

Selzentry 150 mg

  • Evening

Picture of HIV drug Selzentry (maraviroc) 150 mg tablets

Selzentry 150 mg

Note: This dose recommended if Selzentry is used in a regimen that contains Crixivan, Invirase, Lexiva, Norvir, Prezista, Reyataz, Viracept, or Rescriptor; consult your medical provider

two 300 mg tablets, two times a day

  • Morning

Picture of HIV drug Selzentry (maraviroc) 300 mg tabletsPicture of HIV drug Selzentry (maraviroc) 300 mg tablets

Selzentry 300 mg

  • Evening

Picture of HIV drug Selzentry (maraviroc) 300 mg tabletsPicture of HIV drug Selzentry (maraviroc) 300 mg tablets

Selzentry 300 mg

Note: This dose recommended if Selzentry is used in a regimen that contains Sustiva or etravirine (an experimental drug) without Crixivan, Invirase, Lexiva, Norvir, Prezista, Reyataz, or Viracept; consult your medical provider

Notes on taking this medication

  • Many medications used to treat HIV-related illnesses and other conditions interact with Selzentry. Persons using Selzentry with these medications may need an adjustment to their dosage of Selzentry; consult your medical provider
  • Selzentry only works against HIV that binds to a molecule called CCR5 (this type of HIV is sometimes referred to as "R5 virus"). Before you start taking Selzentry, you must have a special blood test (called a tropism assay) to determine whether you have R5 virus or another type of HIV
  • The FDA has approved Selzentry for use only by persons whose HIV is resistant to many other HIV medications


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index